RELA-induced MiR-21 Exerts Oncogenic Effects on PDAC via Targeting of ARHGAP24

Lanting Yu1,2, Jiawei Lu1,2, Haoran Xie1,2

  • 1Department of Gastroenterology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China.

Journal of Cancer
|July 11, 2022
PubMed

Insights

RELA promotes pancreatic cancer by increasing miR-21, which drives tumor growth and inhibits apoptosis. This miR-21 targets ARHGAP24, a tumor suppressor, highlighting their potential as pancreatic ductal adenocarcinoma (PDAC) biomarkers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • Inflammation is a known factor in pancreatic ductal adenocarcinoma (PDAC) development.
  • MicroRNAs (miRNAs) play a role in PDAC occurrence and progression.
  • The involvement of the inflammatory regulator RELA in miRNA-mediated PDAC regulation requires further investigation.

Purpose of the Study:

  • To investigate the role of miR-21 in pancreatic ductal adenocarcinoma (PDAC).
  • To elucidate the upstream regulatory mechanism of miR-21 involving RELA.
  • To determine the functional effects and target genes of miR-21 in PDAC.

Main Methods:

  • In situ hybridization to assess miR-21 expression in PDAC tissues.
  • Chromatin immunoprecipitation and dual-luciferase reporter assays to confirm RELA's regulation of miR-21.
  • In vitro assays (cell viability, EdU staining, flow cytometry) and in vivo xenograft assays to evaluate miR-21's functional effects.
  • Analysis of miR-21's direct target gene, ARHGAP24.

Main Results:

  • miR-21 expression is increased in PDAC tissues.
  • Transcription factor RELA directly modulates miR-21 transcription in PDAC cell lines.
  • miR-21 promotes cell proliferation and cell cycle progression while inhibiting apoptosis in vitro.
  • miR-21 accelerates tumor growth in vivo.
  • miR-21 directly targets and downregulates the tumor suppressor gene ARHGAP24.

Conclusions:

  • RELA-mediated upregulation of miR-21 contributes to PDAC progression.
  • miR-21 promotes PDAC by inhibiting apoptosis and enhancing proliferation.
  • ARHGAP24 is a tumor suppressor targeted by miR-21 in PDAC.
  • Both miR-21 and ARHGAP24 show strong associations with clinical features and may serve as valuable prognostic biomarkers for PDAC.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.0K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K